NDC product
RELAFEN
NDC 0029-4851 · GlaxoSmithKline LLC
Key facts
| Product NDC | 0029-4851 |
|---|---|
| Proprietary name | RELAFEN |
| Labeler | GlaxoSmithKline LLC |
| Marketing category | NDA |
| Application number | NDA019583 |
| Marketing start | Feb 1, 2006 |
| Marketing end | Feb 11, 2011 |
| Listing certified through | Feb 11, 2011 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: